Bcl-2 Family Proteins: Strategies for Overcoming Chemoresistance in Cancer
- 1 January 1997
- book chapter
- Published by Elsevier
- Vol. 41, 501-532
- https://doi.org/10.1016/s1054-3589(08)61070-4
Abstract
No abstract availableThis publication has 133 references indexed in Scilit:
- Bcl-xL forms an ion channel in synthetic lipid membranesNature, 1997
- Membrane Topology of the Colicin A Pore-forming Domain Analyzed by Disulfide Bond EngineeringPublished by Elsevier ,1996
- Bcl-2 Overexpression Blocks Activation of the Death Protease CPP32/Yama/ApopainBiochemical and Biophysical Research Communications, 1996
- Nitric oxide induced poly(ADP‐ribose) polymerase cleavage in RAW 264.7 macrophage apoptosis is blocked by Bcl‐2FEBS Letters, 1996
- A Peptide Sequence from Bax That Converts Bcl-2 into an Activator of ApoptosisPublished by Elsevier ,1996
- Inhibitors of permeability transition interfere with the disruption of the mitochondrial transmembrane potential during apoptosisFEBS Letters, 1996
- The protein bcl-2 alpha does not require membrane attachment, but two conserved domains to suppress apoptosis.The Journal of cell biology, 1994
- Refined structure of the pore-forming domain of colicin A at 2.4 Å resolutionJournal of Molecular Biology, 1992
- Mitochondrial protein p26 BCL2 reduces growth factor requirements of NIH3T3 fibroblasts*1Experimental Cell Research, 1991
- Release of mitochondrial matrix proteins through a Ca2+-requiring, cyclosporin-sensitive pathwayBiochemical and Biophysical Research Communications, 1989